Fraxodi 5700IU Injection
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Salt Composition
Nadroparin (5700IU)
Overview Fraxodi 5700IU Injection
Heparin 5700IU Injection is an antithrombotic medication preventing and treating dangerous blood clots. It inhibits existing clot growth and the formation of new clots in vital areas such as the legs, lungs, brain, and heart. Administration is exclusively by a healthcare professional (doctor or nurse). Dosage and treatment duration are personalized, considering your health status, response to therapy, specific condition, age, and weight. Continued injections are crucial, even without symptoms, to prevent future complications; discontinuation risks clot formation. Potential side effects include bleeding, injection site reactions, elevated liver enzymes, and hematoma at the injection site. Minimize activities increasing bleeding risk while using this medication, exercising caution with sharp objects (e.g., razors). Prior to treatment, inform your physician about hypertension, diabetes, or recent stroke. This medication is contraindicated with active bleeding. Disclose all other medications to your doctor to ensure compatibility. Pregnant or breastfeeding individuals should seek medical advice before using this injection.
Uses of Fraxodi 5700IU Injection
Preventing and managing blood clot formation
Major Benefits of Fraxodi 5700IU Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Fraxodi 5700IU Injection:
- Injection site reaction
- Bleeding
- Injection site hematoma
- Increased liver enzymes
How to use Fraxodi 5700IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fraxodi 5700IU Injection works:
Fraxodi 5700 IU injection is a medication that thins the blood, thus hindering the development of dangerous blood clots.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fraxodi 5700IU Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Fraxodi 5700IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Fraxodi 5700IU Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Fraxodi 5700IU Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Fraxodi 5700IU Injection to individuals with advanced renal impairment. Dosage modification of Fraxodi 5700IU Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Fraxodi 5700IU Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Fraxodi 5700IU Injection :
Omit a Fraxodi 5700IU Injection dose? Seek your physician's advice.
Facts to Know About Fraxodi 5700IU Injection
| Label | Value |
|---|---|
| Chemical Type | Low-molecular-weight heparin |
| Developing Habits | No. |
| Type of Treatment | KINSHIP |
| Action Class | Low-molecular-weight heparin (LMWH) |
3,018 People bought this recently